Olivier Van Obberghen > Quinz > Vilvoorde, Belgium > Lawyer Profile

Quinz
MEDIALAAN 28B
1800 VILVOORDE
Belgium

Work Department

Life Sciences & Technology
Intellectual property
Media and entertainment

Position

Olivier Van Obberghen is an R&D, commercial transactions and M&A lawyer with a focus on the Life Sciences and Innovative Technologies sectors.  He also advises companies active in the consumer goods and media industries.

His Life Sciences practice has three main areas of expertise: (i) transactional work (R&D and supply chain contracts; distribution; licensing and M&A), (ii) compliance advice (transparency; promotion of drug products; patient involvement) and (iii) regulatory assistance.

Career

Partner – Quinz | September 2011 – Present
External Legal Counsel (secondee) – UCB Pharma | February 2009 – September 2011
External Legal Counsel (secondee) – Unilever | March 2008 – August 2011
Partner – Van Obberghen (Attorneys) | February 2003 – August 2011
Associate – Cleary Gottlieb Steen & Hamilton | September 2000 – January 2003

Languages

Dutch, French and English

Memberships

Brussels Bar; Licensing Executive Society, European Centre for Clinical Research Training

Education

  • University of Chicago, Law School, LL.M, 2000
  • Catholic University of Leuven (KU Leuven), LL.B. 1996 and JD 1999 (magna cum laude)

Lawyer Rankings

Belgium > Industry focus: Healthcare and life sciences

(Leading partners)

Olivier Van ObberghenQuinz

Quinz‘s practice stands out for its strong transactional and regulatory capabilities, often advising on transparency regulations, healthcare compliance matters, and competition issues. Olivier Van Obberghen has a solid track record in handling pharma compliance work and supply chain projects; he co-heads the practice with Pieter Wyckmans, who is well versed in advising on market access issues and pricing and reimbursement work. International research collaboration matters form a key pillar of Michiel D’herde‘s practice, and Marion Lapage fields expertise in R&D outsourcing projects and distribution issues. Amber Cockx often advises on digital health matters, and Pauline Meskens focuses on market access and parallel imports issues.